The group of Uede even designed an antibody similar to our used mAb 21–5 which recognized the SVVYGLR of human OPN, which showed promising results in the treatment of rheumatoid arthritis in a primate study [43]. This evidence concerns the gene SPP1 and rheumatoid arthritis.